Analysis of non-benzodiazepinic anxiolytic agents by capillary zone electrophoresis
- 1 April 1995
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 13 (4-5) , 505-509
- https://doi.org/10.1016/0731-7085(95)01340-q
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Quantitative aspects of the application of capillary electrophoresis to the analysis of pharmaceuticals and drug related impuritiesJournal of Chromatography A, 1993
- Quantitative Pharmaceutical Analysis by Capillary ElectrophoresisJournal of Liquid Chromatography, 1993
- Analysis of new serotonergic anxiolytics by liquid chromatographyJournal of Pharmaceutical and Biomedical Analysis, 1992
- Preclinical profile of the pyrimidinylpiperazinyl imide compound WY-47,846: A potential anxiolyticDrug Development Research, 1989
- Determination of a buspirone metabolite in plasma samplesJournal of Pharmaceutical and Biomedical Analysis, 1988
- IPSAPIRONE, A POTENT AND SELECTIVE 5-HT1A-RECEPTOR LIGAND WITH ANXIOLYTIC AND ANTIDEPRESSANT PROPERTIESDrugs of the Future, 1988
- Reduction in cortical 5HT2 receptor sensitivity after continuous gepirone treatmentEuropean Journal of Pharmacology, 1985
- Capillary gas chromatographic—mass spectrometric determination of buspirone in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Disposition and metabolism of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in the ratXenobiotica, 1983
- Identification and quantitation of 1-(2-pyrimidinyl)piperazine, an active metabolite of the anxiolytic agent buspirone, in rat plasma and brainJournal of Chromatography A, 1982